We demonstrated that constitutive deletion of endogenous Tyrobp in a mouse model of HD normalizes microglial morphology, impedes the reduction of PSD-95 and the increase in CD68, improves motor function, prevents astrogliosis, and downregulates transcriptomic pathways altered in HD human brain. The gene discussed is TYROBP; the disease is Huntington disease.